Your browser doesn't support javascript.
loading
Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis.
Di, Mengyang; Cui, Can; Kothari, Shalin K; Zeidan, Amer M; Podoltsev, Nikolai A; Neparidze, Natalia; Shallis, Rory M; Wang, Rong; Ma, Xiaomei; Huntington, Scott F.
Affiliation
  • Di M; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Cui C; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT.
  • Kothari SK; Department of Immunobiology, Yale University School of Medicine, New Haven, CT; and.
  • Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Podoltsev NA; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Neparidze N; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT.
  • Shallis RM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Wang R; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT.
  • Ma X; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Huntington SF; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT.
Blood Adv ; 6(11): 3339-3342, 2022 06 14.
Article in En | MEDLINE | ID: mdl-35240689

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell Limits: Humans Language: En Journal: Blood Adv Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell Limits: Humans Language: En Journal: Blood Adv Year: 2022 Type: Article